Evidence map›Paper›PMID 39791207›Full record

ArticleMolecular medicine reports2025

Integrated transcriptomics and proteomics analysis of the impact of iodine‑125 in hepatocellular carcinoma.

Yang Yang, Wei Yang, Jie Shen, Enci Ding

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yang YangThe First Central Clinical School, Tianjin Medical University, Tianjin 300000, P.R. China.
Wei YangDepartment of Cardiology, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan 450000, P.R. China.
Jie ShenThe First Central Clinical School, Tianjin Medical University, Tianjin 300000, P.R. China.
Enci DingThe First Central Clinical School, Tianjin Medical University, Tianjin 300000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is a common cause of cancer‑related mortality and morbidity worldwide. While iodine‑125 (

Indexed as

ApoptosisCarcinoma, HepatocellularCell MovementCell ProliferationGene Expression Regulation, NeoplasticIodine RadioisotopesLiver NeoplasmsProteomicsTranscriptomeCell Line, TumorCell SurvivalGene Expression ProfilingHumansIodine-125Iodine Radioisotopeshepatocellular carcinomaiodine‑125omics analysis

Identifiers

PMID39791207
PMCPMC11736249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.